Takeda submits Takepron for a new indication

Member login

Science News

Bristol-Myers Squibb to acquire ZymoGenetics
Bristol-Myers Squibb and ZymoGenetics, have signed a definitive agreement providing for the acquisition of ZymoGenetics...
Jennerex and Transgene partner for cancer treatment
Jennerex and Transgene, have entered into an exclusive partnership to develop and commercialize JX-594 for...
CROs project growth over 20%
In an effort to assess the trends in Contract and Clinical Research Organizations (CROs)...
BARRX, Medico''s Hirata to jointly distribute radiofrequency system
BARRX Medical has signed an exclusive agreement with Japan''s Medico''s Hirata for distribution of the...
Sinopharm to open pharmaceutical logistics park in Xinjiang
China National Pharmaceutical Industry Corporation (CNPIC), a subsidiary of Sinopharm, has started the construction of...
Israel SC rules in favor of Sun Pharma
Indian pharma giant Sun Pharma, which was fighting a takeover battle with Israeli Pharma major...
Quintiles'' Japanese lab gets CAP accreditation
Quintiles'' new lab in Tokyo, Japan has received accreditation from the College of American Pathologists...

Takeda submits Takepron for a new indication

Takeda announced the submission of an application of the additional indication for Takepron Capsules 15 and Takepron OD Tablets 15 to the Ministry of Health, Labour and Welfare, Japan

Read more BioSpectrum Asia - RSS Feed